Brief: Regent Pacific Group Says Operations Update On Fortacin
04/01/2021 09:51
Jan 4 (Reuters) - Regent Pacific Group Ltd 0575.HK :
* REGENT PACIFIC GROUP LTD- OPERATIONS UPDATE ON FORTACIN
* REGENT PACIFIC GROUP - GROUP GOT HK$5.62 MILLION FROM
WANBANG
PHARMACEUTICAL MARKETING AND DISTRIBUTION
* REGENT PACIFIC-ON SUCCESSFUL APPROVAL FROM NMPA TO
COMMENCE
CLINICAL TRIAL, A PAYMENT OF US$3.20 MILLION NET OF PRC
WITHHOLDING TAX, WILL BE DUE
Source text for Eikon: ID:nHKS2vDj3l
Further company coverage: 0575.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Regent Pacific
See all newsBrief: Regent Pacific Says SenstendTM Approved By NMPA For Premature Ejaculation In China
Brief: Regent Pacific Says Deep Longevity To Launch U.S. Expansion In Q1 2026
Brief: Regent Pacific Shall Allot And Issue 63.4 Million Shares At Hk$0.485 Per Share
Brief: Regent Pacific Announces Submission Of Senstend New Drug Application To NMPA In China
Brief: Regent Pacific Enters Manufacturing And Supply Agreement For SENSTEND